Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients

Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients

Abstract Background The aim of this study was to explore the utility of circulating free DNA (cfDNA) in the evaluation of clinical tumor burden and survival in Chinese patients with metastatic colorectal cancer (mCRC) and to preliminarily summarize some metastatic characteristics associated with mut...

Full description

Bibliographic Details
Main Authors:	Xiaojing Xu, Yiyi Yu, Minna Shen, Mengling Liu, Shengchao Wu, Li Liang, Fei Huang, Chenlu Zhang, Wei Guo, Tianshu Liu
Format:	Article
Language:	English
Published:	BMC 2020-10-01
Series:	BMC Cancer
Subjects:	Metastatic colorectal Cancer (mCRC) Circulating free DNA Tumor burden Survival Metastasis
Online Access:	http://link.springer.com/article/10.1186/s12885-020-07516-7

Similar Items

The Screening and COnsensus Based on Practices and Evidence (SCOPE) Program Results of a Survey on Daily Practice Patterns for Patients with Metastatic Colorectal Cancer—A Swiss Perspective in the Context of an International Viewpoint
by: Alexander R. Siebenhüner, et al.
Published: (2022-08-01)

Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer
by: Chiara Cremolini, et al.
Published: (2023-02-01)

Primary tumor location and survival among metastatic colorectal cancer patients treated with systemic chemotherapy and biologic therapies: Retrospective analysis
by: Majed Ramadan, et al.
Published: (2022-01-01)

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study
by: Sabin Goktas Aydin, et al.
Published: (2023-11-01)

Second-line targeted therapy for metastatic colorectal cancer. Possibilities for choices
by: L. V. Bolotina, et al.
Published: (2018-11-01)

Endothelium-Derived Extracellular Vesicles Associate with Poor Prognosis in Metastatic Colorectal Cancer
by: Afroditi Nanou, et al.
Published: (2020-12-01)

Predictive value of prognostic nutritional and systemic immune-inflammation indices for patients with microsatellite instability-high metastatic colorectal cancer receiving immunotherapy
by: Jiahong Yi, et al.
Published: (2023-05-01)

Predictive and Prognostic Role of Systemic Immune-Inflammation Index (SII) in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil
by: Mateusz Malik, et al.
Published: (2024-09-01)

The Relationship of Smoking and Lymph Node Metastasis with Survival in Colorectal Cancers
by: Sevda Yeşim ÖZDEMİR, et al.
Published: (2022-08-01)

Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC
by: Edward Zheng, et al.
Published: (2024-06-01)

Anlotinib combined with TAS-102 as the third-line treatment for a patient with metastatic colon cancer: A case report
by: Qizheng Li, et al.
Published: (2022-11-01)

Translational analysis and final efficacy of the AVETUX trial – Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer
by: Joseph Tintelnot, et al.
Published: (2022-12-01)

Case report: Durable response from tegafur/gimeracil/oteracil (S-1) combined with fruquintinib and sintilimab as a third-line treatment for MSS metastatic colorectal cancer with a BRAF V600E mutation
by: Chunxia He, et al.
Published: (2024-12-01)

Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance
by: Haisong Xin, et al.
Published: (2023-02-01)

Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib
by: Andrea Abbona, et al.
Published: (2023-02-01)

Racial disparities in metastatic colorectal cancer outcomes revealed by tumor microbiome and transcriptome analysis with bevacizumab treatment
by: Lei Feng, et al.
Published: (2024-01-01)

CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial
by: Yuankai Shi, et al.
Published: (2019-05-01)

Tumor circulating biomarkers in colorectal cancer
by: Raana Bagheri, et al.
Published: (2024-01-01)

Efficacy and safety of fruquintinib dose‐escalation strategy for elderly patients with refractory metastatic colorectal cancer: A single‐arm, multicenter, phase II study
by: Sirui Tan, et al.
Published: (2023-12-01)

Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC
by: Lucia Scarabel, et al.
Published: (2022-11-01)

Discovery, identification and mechanism of chemosensitivity-relate biomarker inter-α-trypsin inhibitor heavy chain 4 in metastatic colorectal cancer
by: Yingxin Zhao, et al.
Published: (2024-07-01)

Irreversible electroporation for colorectal cancer liver metastasis: a review
by: Yilun Koethe, et al.
Published: (2022-12-01)

Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial
by: Marco Maria Germani, et al.
Published: (2024-02-01)

Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer
by: Luís Nunes, et al.
Published: (2024-11-01)

Case report: Bullous pemphigoid associated with sintilimab therapy for pMMR/MSS colorectal cancer
by: Ting Wang, et al.
Published: (2023-03-01)

Differences in tissue-associated bacteria between metastatic and non-metastatic colorectal cancer
by: Peng Zhou, et al.
Published: (2023-06-01)

Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer
by: Emaan Haque, et al.
Published: (2022-12-01)

Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer
by: Benjamin A. Weinberg, et al.
Published: (2021-12-01)

CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS/BRAF Wild-Type mCRC Patients
by: Stefania Napolitano, et al.
Published: (2022-06-01)

The Effective Role of Targeted Therapy in Advanced Colorectal Cancer
by: Sarah K. Obay, et al.
Published: (2022-07-01)

OXALIPLATIN/5-FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan N. Davidov
Published: (2013-12-01)

Assessment of the quality of life in metastatic colorectal cancer patients with KRAS gene mutant: a case-control study
by: Fahmideh Bagrezaei, et al.
Published: (2025-01-01)

THE IMPORTANCE OF CIRCULATING TUMOR DNA IN THE ASSESSMENT OF METASTATIC COLORECTAL CANCER TREATMENT EFFECTIVNE
by: M. I. Sluzhev, et al.
Published: (2021-10-01)

PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH FIRST - LINE CHEMOTHERAPY
by: Deyan Davidov
Published: (2017-05-01)

Markers of metastatic colorectal cancer
by: Piotr Myśliwiec, et al.
Published: (2019-05-01)

Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line
by: Salah Mabrook Khallaf, et al.
Published: (2024-01-01)

Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study
by: Umberto Malapelle, et al.
Published: (2020-09-01)

Case Report: Chemoimmunotherapy in microsatellite-instability-high advanced goblet cell carcinoma of the colon
by: Arda Ulaş Mutlu, et al.
Published: (2023-07-01)

Cetuximab in treatment of metastatic colorectal cancer: background and clinical observation
by: A. D. Darenskaya, et al.
Published: (2018-11-01)

Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China
by: Miaomiao Gou, et al.
Published: (2022-07-01)